Study guide
13.2 Refeeding Syndrome and Complications of Parenteral Nutrition
Nutritionist-Dietitian Licensure Examination NDLE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Licensure Law, Ethics, and the Clinical Nutritionist-Dietitian
1.1 NDLE Format, Scoring Rules, and RA 10862 Licensure Requirements 1.2 Scope of Practice, Professional Ethics, and Discipline under RA 10862 1.3 Role of the Clinical Nutritionist-Dietitian, Diet Orders, and Standard Hospital Diets
2 Chapter 2: Anatomy and Physiology for Nutrition I
2.1 Cells, Tissues, Membranes, and the Immune and Lymphatic Systems 2.2 The Digestive System: Organs, Enzymes, GI Hormones, and the Liver 2.3 Endocrine and Nervous System Regulation of Metabolism and Appetite
3 Chapter 3: Anatomy and Physiology II, Energy, and Carbohydrate Metabolism
3.1 Cardiovascular, Respiratory, Renal, Musculoskeletal, and Reproductive Systems 3.2 Energy Metabolism and Energy Expenditure Calculations 3.3 Carbohydrate Chemistry, Digestion, and Glycemic Pathways
4 Chapter 4: Protein, Lipid, Mineral, and Fluid Biochemistry
4.1 Protein Chemistry, Amino Acid Metabolism, and Nitrogen Balance 4.2 Lipid Metabolism, Lipoproteins, and Cardiovascular Biomarkers 4.3 Minerals, Water, Electrolytes, and Acid-Base Balance
5 Chapter 5: Basic Nutrition: Vitamins, Minerals, and the PDRI
5.1 Vitamin Biochemistry: Coenzyme Functions and Deficiency Syndromes 5.2 Vitamins and Minerals: PDRI Values, Food Sources, Bioavailability, Stability, and Toxicity 5.3 Philippine Dietary Reference Intakes (PDRI 2015), Pinggang Pinoy, and Dietary Guidelines
6 Chapter 6: Diet Computation and Clinical Nutrition Assessment
6.1 Food Exchange Lists, Meal Plan Computation, Food Labels, and Nutrient Density 6.2 Computing Desirable Body Weight, Total Energy Requirement, and the Diet Prescription 6.3 ABCD Methods of Clinical Nutrition Assessment
7 Chapter 7: Nutrition Diagnosis, Life-Stage Assessment, and Laboratory Data
7.1 Nutrition Diagnosis, PES Statements, and Medical Record Documentation 7.2 Pediatric, Obstetric, and Geriatric Clinical Nutritional Assessment 7.3 Interpreting Biochemical and Laboratory Data in Nutrition Assessment
8 Chapter 8: Drug-Nutrient Interactions, Diabetes, and Weight Disorders
8.1 Drug-Nutrient Interactions and Nutrient Depletion 8.2 MNT for Diabetes Mellitus and Endocrine Disorders 8.3 MNT for Overweight, Obesity, and Underweight
9 Chapter 9: MNT for Cardiovascular, Renal, and Gastrointestinal Disease
9.1 MNT for Cardiovascular Disease, Hypertension, and Dyslipidemia 9.2 MNT for Renal Diseases (AKI, CKD Stages 1-5, Dialysis, and Nephrotic Syndrome) 9.3 MNT for Disorders of the Gastrointestinal Tract
10 Chapter 10: MNT for Liver, Infectious, Respiratory, Allergic, and Neurologic Conditions
10.1 MNT for Liver, Gallbladder, and Pancreatic Disorders 10.2 MNT for Fevers, Infections, Diarrheal Disease, and Respiratory Disorders 10.3 MNT for Food Allergy and Intolerance, Skin, Rheumatic, Musculoskeletal, and Neurologic Disorders
11 Chapter 11: Critical Illness, Oncology, HIV, and Protein-Energy Malnutrition
11.1 MNT in Critical Illness, Sepsis, Trauma, and Burns 11.2 MNT in Oncology: Cancer Cachexia and Treatment Side Effects 11.3 MNT for HIV/AIDS and for Protein-Energy Malnutrition in Children and Adults
12 Chapter 12: Metabolic Disorders, Dysphagia, and Enteral Nutrition
12.1 MNT for Inborn Errors of Metabolism and Eating Disorders 12.2 Dysphagia, IDDSI Texture-Modified Diets, and Adaptive Feeding 12.3 Enteral Nutrition: Indications, Formula Selection, Access Routes, and Complications
13 Chapter 13: Parenteral Nutrition, Refeeding, and Nutrition Counseling
13.1 Parenteral Nutrition: Indications, Access, Substrates, and Compounding 13.2 Refeeding Syndrome and Complications of Parenteral Nutrition 13.3 Nutrition Counseling and Behavior Change Theories
14 Chapter 14: Nutrition Updates: Supplements, Diet Trends, and Sports Nutrition
14.1 Dietary Supplements, Herbal Medicines, and Functional Foods 14.2 Vegetarian Diets, Protein Complementation, and Popular Diet Trends 14.3 Sports Nutrition and Workplace Wellness Programs
15 Chapter 15: Community Nutrition and Population Assessment
15.1 Community Nutrition Principles, the ND's Roles, and the Philippine Health Delivery System 15.2 Nutritional Epidemiology and Health Status Indicators in the Philippines 15.3 Assessment of Community Nutritional Status and Operation Timbang Plus (OPT+)
16 Chapter 16: Dietary Surveys, Nutrition Research, and Surveillance
16.1 Food Consumption Surveys, Biochemical Tests in Surveys, and Clinical Signs of Deficiency 16.2 Food and Nutrition Research Methods, Sampling, Sample Size, and Research Ethics 16.3 National Nutrition Surveys, Demographic Data, and Designing a Nutrition Surveillance System
17 Chapter 17: Nutrition Education and Program Evaluation
17.1 Nutrition Education: Definition, Principles of Learning, Methods, and Teaching Aids 17.2 Designing a Nutrition Education Program and Measuring Customer Satisfaction 17.3 Program Planning Cycle, SMART Objectives, and Types of Evaluation
18 Chapter 18: Program Planning, Interventions, and Food Security
18.1 Nutrition Program Planning: Needs, Priorities, Constraints, Goals, and Using Evaluation Results 18.2 Nutrition Interventions and Programs for Specific Population Groups 18.3 Food and Nutrition Security, Dietary Diversity, and Vulnerable Populations
19 Chapter 19: Nutrition Governance, Networking, and Program History
19.1 National Nutrition Council (NNC) Structure and Philippine Plan of Action for Nutrition (PPAN) 19.2 Nutrition Agencies, Networking, Community Linkages, Teamwork, and Nutrition Legislation 19.3 Development of Philippine Nutrition Programs and the Country's Nutrition Problems
20 Chapter 20: Fortification, Feeding, and First 1,000 Days Laws
20.1 Food Fortification (RA 8976), Salt Iodization (RA 8172), and the 2024 Salt Industry Law 20.2 Supplementary Feeding Programs (RA 11037) and DSWD/DepEd Interventions 20.3 First 1,000 Days Law (RA 11148) and Maternal-Child Interventions
21 Chapter 21: Nutrition in the Life Cycle I
21.1 Infant and Young Child Feeding (IYCF), Philippine Milk Code (EO 51), and RA 10028 21.2 Nutrition in Pregnancy and Lactation: Physiology, Needs, Meal Patterns, and Problems 21.3 Nutrition from Infancy to School Age: Growth, Feeding Patterns, Problems, and School Programs
22 Chapter 22: Nutrition in the Life Cycle II
22.1 Nutrition for Adolescents and Adults: Growth Spurt, Risk Factors, and NCD Prevention 22.2 Nutrition for Older Adults: Aging Changes, Needs, Problems, and Senior Citizen Programs
23 Chapter 23: Food Science and Plant Foods
23.1 Chemistry of Starches, Proteins, Lipids, and Emulsions in Cooking 23.2 Food Pigments, Flavor Chemistry, and Browning Reactions (Maillard & Enzymatic) 23.3 Fruits, Vegetables, and Legumes: Classification, Market Forms, Quality, Storage, and Cookery
24 Chapter 24: Animal Foods, Cereals and Baking, and Cooking Methods
24.1 Meat, Poultry, Fish, Eggs, and Milk: Structure, Quality, Storage, and Cookery 24.2 Cereals, Flour Mixtures and Baking, Sugar Cookery, Fats and Oils, and Beverages 24.3 Heat Transfer, Dry-Heat and Moist-Heat Cooking Methods, and Filipino Cooking Techniques
25 Chapter 25: Culinary Skills, Family Meal Planning, and Food Quality
25.1 Culinary Vocabulary, Knife Cuts, Basic Sauces, and Accurate Measurement 25.2 Meal Planning for the Family, Food Budgeting, and Recipe Development 25.3 Sensory Evaluation, Objective Food Tests, and Quality Assurance in Food Production
26 Chapter 26: Food Microbiology, Preservation, and Food Law
26.1 Foodborne Pathogens, Microbial Kinetics, and FAT TOM Parameters 26.2 Food Preservation Methods, Thermal Processing, and Packaging 26.3 Philippine Food Laws, Regulatory Agencies, and Food Labeling
27 Chapter 27: Sanitation, HACCP, Waste, and Workplace Safety
27.1 Sanitation Standard Operating Procedures (SSOP) and Good Manufacturing Practices (GMP) 27.2 HACCP Principles and Critical Control Point Management in Food Service 27.3 Waste Management, Pest Control Regulation, and Occupational Safety in Food Service
28 Chapter 28: Food Service Systems, Production Planning, and Menus
28.1 Types of Food Service Delivery Systems (Conventional, Ready-Prepared, Commissary, Assembly) 28.2 Forecasting, Production Planning, and Quantity Food Production Techniques 28.3 Institutional Menu Planning, Modified Diets, and Recipe Standardization
29 Chapter 29: Distribution, Purchasing, and Storage
29.1 Food Distribution and Service Systems in Hospitals and Other Institutions 29.2 Food Purchasing Methods, Specifications, and Receiving 29.3 Storage Management, Inventory Control, and Valuation
30 Chapter 30: Cost Control, Financial Management, and Facility Layout
30.1 Food Cost Accounting, Yield Testing, and Portion Control Formulas 30.2 Menu Pricing Models, Break-Even Analysis, and Financial Statements 30.3 Food Service Facility Layout, Equipment Selection, and Workflow Ergonomics
31 Chapter 31: Equipment, Management, and Human Resources
31.1 Food Service Equipment: Selection, Capacity, Life-Cycle Cost, Depreciation, and Maintenance 31.2 Management Functions, Theories, Leadership Styles, and Managing Change in Food Service 31.3 Human Resource Management: Job Design, Recruitment, Training, Appraisal, and Discipline
32 Chapter 32: Labor Law, Permits, and Food Service Marketing
32.1 Philippine Labor Laws and Business Permits for Food Service Operations 32.2 Food Service Marketing, Menu Engineering, and Sustainable Food Service
13.2 Refeeding Syndrome and Complications of Parenteral Nutrition
Key Takeaways Explain This Topic AI
Refeeding syndrome is a life-threatening metabolic collapse triggered by rapid carbohydrate reintroduction in severely starved patients, wherein an insulin surge drives massive intracellular uptake of phosphate, potassium, and magnesium, causing acute hypophosphatemia, arrhythmias, and cardiopulmonary arrest.
Refeeding prevention protocols mandate identifying high-risk criteria (NICE guidelines), correcting baseline electrolyte deficits, administering prophylactic thiamine (100–300 mg/day) before feeding, initiating energy at 10–15 kcal/kg/day, and performing daily electrolyte surveillance.
A central line lumen used for parenteral nutrition should be dedicated to it and not used for blood draws or other infusions, to reduce catheter-related bloodstream infection.
Parenteral nutrition-associated liver disease is reduced by avoiding overfeeding, cycling infusions over 12-16 hours, using mixed-oil lipid emulsions, and starting trophic enteral feeding when possible.
Last updated: October 2026
Two dangerous complications of nutrition support are tested repeatedly: refeeding syndrome, which can occur with oral, enteral, or parenteral feeding, and the long-term complications of parenteral nutrition.
Refeeding Syndrome: Molecular Pathophysiology & Prevention Protocols
Refeeding Syndrome is a potentially lethal constellation of metabolic and electrolyte derangements that occurs when nutritional support (carbohydrate calories via oral, enteral, or parenteral routes) is introduced too rapidly in severely malnourished, cachectic, or starved patients. Prolonged Starvation / Chronic Malnutrition
- Depleted glycogen, shifted to fat/ketones
- Low basal insulin, elevated glucagon
- Total-body electrolyte depletion (P, K, Mg)
- │
- ▼
- RAPID CARBOHYDRATE REINTRODUCTION
- │
- ▼
- MASSIVE ENDOGENOUS INSULIN SURGE
- │
- ┌────────────────────────────┼────────────────────────────┐
- ▼ ▼ ▼
- [Electrolyte Shift] [Thiamine Depletion] [Renal Na+ Retention]
- Rapid cellular uptake of - TPP exhausted by sudden - Insulin stimulates renal
- Phosphate, Potassium, carbohydrate glycolysis sodium reabsorption
- and Magnesium - Pyruvate cannot form - Extracellular fluid expansion
- │ Acetyl-CoA Pulmonary edema
- ▼ - Severe Lactic Acidosis Congestive heart failure
- Severe Hypophosphatemia Wernicke Encephalopathy
- Severe Hypokalemia - Wet Beriberi
- Severe Hypomagnesemia
- │
- ▼
- Cardiac Arrhythmias (Torsades de pointes, VFib)
- Respiratory Diaphragmatic Paralysis (ATP exhaustion)
- Rhabdomyolysis, Seizures, Sudden Cardiopulmonary Death
- The Molecular Mechanism
Starvation Physiology: During prolonged starvation, insulin secretion drops markedly, while glucagon and catecholamines rise. The body downregulates glycolysis and depends on fatty acid oxidation and ketone bodies for energy. While serum electrolyte concentrations (phosphate, potassium, magnesium) may appear normal in baseline blood draws due to hemoconcentration and intracellular extrusion, total body intracellular stores are severely depleted .
The Insulin Spike: When carbohydrates (dextrose) are reintroduced, blood glucose levels rise, prompting the pancreatic β \beta β -cells to secrete a massive surge of insulin .
Intracellular Shift of Electrolytes: Insulin stimulates the cell membrane N a + / K + Na^+/K^+ N a + / K + ATPase pump and initiates protein, glycogen, and fat synthesis. These anabolic pathways drive a massive, rapid influx of phosphate, potassium, magnesium, and water from the extracellular fluid into the intracellular compartment.
The Cascade of Clinical Disasters:
Severe Hypophosphatemia ( < 1.0 mg/dL <1.0\text{ mg/dL} < 1.0 mg/dL / < 0.3 mmol/L <0.3\text{ mmol/L} < 0.3 mmol/L ): The undisputed hallmark of refeeding syndrome . Intracellular glucose phosphorylation rapidly consumes remaining inorganic phosphate, depleting Adenosine Triphosphate (ATP) and 2,3-Diphosphoglycerate (2,3-DPG) in red blood cells. Loss of 2,3-DPG shifts the oxyhemoglobin dissociation curve to the left, impairing oxygen release to tissues. ATP depletion results in acute diaphragmatic paralysis, respiratory failure, inability to wean from mechanical ventilation, impaired cardiac contractility, acute congestive heart failure, rhabdomyolysis, paresthesias, seizures, and death.
Severe Hypokalemia ( < 3.0 mEq/L <3.0\text{ mEq/L} < 3.0 mEq/L ): Massive potassium uptake into cells causes severe hypokalemia, inducing lethal ventricular arrhythmias (ventricular tachycardia, fibrillation, asystole), paralytic ileus, and muscle flaccidity.
Severe Hypomagnesemia ( < 1.2 mg/dL <1.2\text{ mg/dL} < 1.2 mg/dL ): Magnesium is a necessary cofactor for the N a + / K + Na^+/K^+ N a + / K + ATPase pump and hundreds of metabolic enzymes. Hypomagnesemia triggers cardiac dysrhythmias ( Torsades de pointes ), neuromuscular tremors, tetany, and refractory hypokalemia and hypocalcemia.
Acute Thiamine (Vitamin B 1 B_1 B 1 ) Depletion: Thiamine pyrophosphate (TPP) is an indispensable cofactor for pyruvate dehydrogenase (converting pyruvate to acetyl-CoA) and transketolase . The sudden carbohydrate load overwhelms minimal residual thiamine stores. Inability to metabolize pyruvate forces conversion to lactate, triggering severe lactic acidosis , acute Wernicke encephalopathy (mental confusion, ataxia, ophthalmoplegia/nystagmus), and wet beriberi (acute high-output heart failure).
Sodium Retention and Fluid Overload: Insulin acts directly on renal distal convoluted tubules, stimulating sodium reabsorption. Fluid follows sodium, expanding extracellular volume and precipitating acute pulmonary edema and biventricular heart failure.
Clinical Criteria for High Risk of Refeeding Syndrome (NICE Guidelines)
Risk Level National Institute for Health and Care Excellence (NICE) Clinical Criteria
Major Risk (Patient has ≥ 1 \ge 1 ≥ 1 of these criteria) BMI < 16 kg/m 2 \text{BMI} < 16\text{ kg/m}^2 BMI < 16 kg/m 2 ; Unintentional weight loss > 15 % >15\% > 15% in preceding 3 to 6 months; Little or no nutritional intake for > 10 consecutive days >10\text{ consecutive days} > 10 consecutive days ; Low baseline serum levels of phosphate, potassium, or magnesium prior to feeding
Significant Risk (Patient has ≥ 2 \ge 2 ≥ 2 of these criteria) BMI < 18.5 kg/m 2 \text{BMI} < 18.5\text{ kg/m}^2 BMI < 18.5 kg/m 2 ; Unintentional weight loss > 10 % >10\% > 10% in preceding 3 to 6 months; Little or no nutritional intake for > 5 consecutive days >5\text{ consecutive days} > 5 consecutive days ; History of alcohol abuse or drug therapy including insulin, chemotherapy, diuretics, or antacids
High-Risk Clinical Populations: Chronic alcoholism, anorexia nervosa, oncology cachexia, morbidly obese patients with massive rapid weight loss (post-bariatric surgery), elderly living alone with protracted malnutrition, chronic malabsorptive states (celiac, Crohn's), and post-op surgical patients kept NPO for > 7 – 10 >7–10 > 7–10 days on unsupplemented IV fluids (D5W).
- Evidence-Based Prevention and Management Protocol PATIENT AT HIGH RISK OF REFEEDING
- │
- ▼
- [STEP 1: PRE-FEEDING ELECTROLYTE CORRECTION]
- Check baseline serum Phosphate, K+, Mg++, Ca++
- AGGRESSIVELY CORRECT DEFICITS BEFORE FEEDING
- │
- ▼
- [STEP 2: PROPHYLACTIC THIAMINE ADMINISTRATION]
- Administer Thiamine 100–300 mg/day IV or oral
PLUS balanced multivitamin BEFORE ANY CALORIES!
- Continue daily for at least 3 to 5 days
- │
- ▼
- [STEP 3: 'START LOW AND ADVANCE SLOW']
- Initiate feeding at 10 to 15 kcal/kg/day
- (or <= 50% of estimated resting requirements)
- Extreme risk (BMI < 14): start at 5–10 kcal/kg/day
- Limit dextrose: <= 100–150 g/day (GIR <= 1.5–2.0)
- │
- ▼
- [STEP 4: INTENSIVE ELECTROLYTE SURVEILLANCE]
- Monitor serum Phosphate, K+, Mg++ daily for 7 days
- Re-supplement electrolytes aggressively
- Restrict sodium (<1 mEq/kg/day) to prevent edema
- │
- ▼
- [STEP 5: GRADUAL CALORIC ADVANCEMENT]
- Advance calories by 200–300 kcal/day every 1–2 days
- ONLY IF electrolytes remain completely stable
- Reach full nutritional target by Day 4 to Day 7
- PN Complications and Metabolic Monitoring Protocols
- 1. Infectious Complications: Catheter-Related Bloodstream Infections (CRBSI)
Etiology: CRBSI is the most common severe infectious hazard in parenteral nutrition support. Major pathogens include Staphylococcus epidermidis (coagulase-negative staph), Staphylococcus aureus , Candida albicans , and enteric gram-negative bacilli.
Prevention Protocols: Strict aseptic insertion technique using chlorhexidine gluconate skin antisepsis; full sterile barrier precautions (sterile gown, gloves, mask, cap, large full-body drape); transparent semipermeable dressing over exit site.
The Dedicated PN Lumen Rule: A central catheter lumen designated for PN must be strictly dedicated to parenteral nutrition . Never draw blood, administer IV push medications, piggyback antibiotics, or measure Central Venous Pressure (CVP) through the PN line!
2. Hepatobiliary Complications: PNALD and Cholestasis
Parenteral Nutrition-Associated Liver Disease (PNALD) encompasses a clinical spectrum that can progress to end-stage cirrhosis:
Hepatic Steatosis: Occurs early, presenting with mild-to-moderate elevations in ALT and AST. Driven primarily by caloric overfeeding and excessive glucose infusion rates ( G I R > 5 mg/kg/min GIR > 5\text{ mg/kg/min} G I R > 5 mg/kg/min ) driving de novo lipogenesis.
Cholestasis: Occurs with prolonged PN ( > 2 to 4 weeks >2\text{ to }4\text{ weeks} > 2 to 4 weeks ), characterized by progressive elevations in direct (conjugated) bilirubin, alkaline phosphatase, and GGT. Driven by lack of enteral stimulation (absence of CCK release leads to biliary stasis and gallbladder sludge/cholelithiasis) and toxicity from phytosterols present in 100% soybean-based IVLE.
Prevention and Management:
Avoid total caloric overfeeding; maintain GIR < 4 to 5 mg/kg/min <4\text{ to }5\text{ mg/kg/min} < 4 to 5 mg/kg/min .
Cycle PN Infusions: Transition from continuous 24-hour infusion to cyclic infusion over 12 to 16 hours daily . An 8-to-12-hour "PN-free window" allows serum insulin levels to drop, promoting hepatic glycogen and lipid mobilization.
Switch from 100% soybean IVLE to multi-oil SMOF lipid emulsions containing fish oil.
Initiate Trophic Enteral Feeds: Administer even minimal enteral formula ( 10 to 20 mL/hr 10\text{ to }20\text{ mL/hr} 10 to 20 mL/hr ) to stimulate duodenal CCK release, promoting gallbladder contraction and bile flow.
3. Metabolic Bone Disease
Long-term PN therapy ( > 3 months >3\text{ months} > 3 months ) can induce osteopenia, osteoporosis, or osteomalacia. Etiological factors include chronic hypercalciuria (induced by high-protein amino acid loads), chronic metabolic acidosis, vitamin D deficiency/toxicity, and trace aluminum contamination from calcium/phosphate salt compounding vials. Management involves monitoring DXA bone scans, minimizing excessive amino acid loads, and correcting hypercalciuria.
4. Glycemic Instability and Discontinuation Protocols
Hyperglycemia ( > 180 mg/dL >180\text{ mg/dL} > 180 mg/dL ): Increases susceptibility to CRBSI, induces osmotic diuresis, and exacerbates systemic inflammation. Manage by adding regular human insulin directly into the PN admixture (starting at 0.1 to 0.2 units per gram of dextrose 0.1\text{ to }0.2\text{ units per gram of dextrose} 0.1 to 0.2 units per gram of dextrose ) or utilizing an external IV insulin infusion.
Rebound Hypoglycemia: Abrupt cessation of a hypertonic dextrose PN infusion leaves circulating endogenous insulin levels high, causing a rapid plunge in plasma glucose.
Safe Discontinuation Protocol:
Taper the infusion rate by 50 % 50\% 50% for 1 to 2 hours prior to stopping.
If a central line is lost unexpectedly or a PN bag runs dry, immediately hang 10 % 10\% 10% Dextrose in Water (D10W) at the same infusion rate to prevent rebound hypoglycemia.
Transitioning from PN to Enteral/Oral Nutrition:
Introduce trophic enteral feeds as soon as bowel motility returns.
When enteral or oral feeds reach ≥ 60 % \ge 60\% ≥ 60% of estimated caloric and protein needs, taper the PN infusion rate by 50%.
Completely discontinue PN when enteral or oral intake reliably matches ≥ 75 % to 80 % \ge 75\%\text{ to }80\% ≥ 75% to 80% of total nutritional requirements across 48 consecutive hours.